These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15111770)

  • 41. Catechol-O-methyltransferase gene polymorphisms in benign prostatic hyperplasia and sporadic prostate cancer.
    Tanaka Y; Sasaki M; Shiina H; Tokizane T; Deguchi M; Hirata H; Hinoda Y; Okayama N; Suehiro Y; Urakami S; Kawakami T; Kaneuchi M; Pookot D; Igawa M; Okuyama A; Ishii N; Dahiya R
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):238-44. PubMed ID: 16492910
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of androgen metabolism genes CYP1B1, PSA/KLK3, and CYP11alpha in prostate cancer risk and aggressiveness.
    Cicek MS; Liu X; Casey G; Witte JS
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2173-7. PubMed ID: 16172228
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Polymorphic catechol-O-methyltransferase gene, soy isoflavone intake and breast cancer in postmenopausal women: a case-control study.
    Wang Q; Wang YP; Li JY; Yuan P; Yang F; Li H
    Chin J Cancer; 2010 Jul; 29(7):683-8. PubMed ID: 20591221
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estrogens, enzyme variants, and breast cancer: a risk model.
    Crooke PS; Ritchie MD; Hachey DL; Dawling S; Roodi N; Parl FF
    Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1620-9. PubMed ID: 16985022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives.
    Hu Z; Song CG; Lu JS; Luo JM; Shen ZZ; Huang W; Shao ZM
    J Cancer Res Clin Oncol; 2007 Dec; 133(12):969-78. PubMed ID: 17562079
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modulatory effect of plasma folate and polymorphisms in one-carbon metabolism on catecholamine methyltransferase (COMT) H108L associated oxidative DNA damage and breast cancer risk.
    Naushad SM; Pavani A; Rupasree Y; Sripurna D; Gottumukkala SR; Digumarti RR; Kutala VK
    Indian J Biochem Biophys; 2011 Aug; 48(4):283-9. PubMed ID: 22053698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Analysis of polymorphisms in genes of insulin receptor substrate-1 and enzymes involved in estrogen biosynthesis and metabolism among breast cancer patients with BRCA1 mutations].
    Bershteĭn LM; Ulybina IuM; Pozharisskiĭ KM; Imianitov EN
    Vopr Onkol; 2009; 55(2):158-64. PubMed ID: 19514368
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Catechol-O-methyltransferase Val 108/158 Met polymorphism in premenopausal breast cancer patients.
    Sazci A; Ergul E; Utkan NZ; Canturk NZ; Kaya G
    Toxicology; 2004 Nov; 204(2-3):197-202. PubMed ID: 15388245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study.
    Lord SJ; Mack WJ; Van Den Berg D; Pike MC; Ingles SA; Haiman CA; Wang W; Parisky YR; Hodis HN; Ursin G
    Breast Cancer Res; 2005; 7(3):R336-44. PubMed ID: 15987428
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Catechol-O-Methyltransferase (COMT) gene polymorphism and breast cancer risk in young women.
    Bergman-Jungeström M; Wingren S
    Br J Cancer; 2001 Sep; 85(6):859-62. PubMed ID: 11556837
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Association of the CYP1B1 gene polymorphism with susceptibility to endometriosis].
    Li YG; Wang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Feb; 26(1):66-9. PubMed ID: 19199255
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Equine catechol estrogen 4-hydroxyequilenin is a more potent inhibitor of the variant form of catechol-O-methyltransferase.
    Li Y; Yao J; Chang M; Nikolic D; Yu L; Yager JD; Mesecar AD; van Breemen RB; Bolton JL
    Chem Res Toxicol; 2004 Apr; 17(4):512-20. PubMed ID: 15089093
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk.
    Reding KW; Weiss NS; Chen C; Li CI; Carlson CS; Wilkerson HW; Farin FM; Thummel KE; Daling JR; Malone KE
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1461-7. PubMed ID: 19383894
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Genetic polymorphism of steroidogenic enzymes and steroid receptor level in tumors of the reproductive system].
    Berstein LM; Zimarina TS; Tsyrlina EV; Kovalevskiĭ AIu; Imianitov EN
    Vopr Onkol; 2004; 50(2):169-73. PubMed ID: 15176218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women.
    Tworoger SS; Chubak J; Aiello EJ; Ulrich CM; Atkinson C; Potter JD; Yasui Y; Stapleton PL; Lampe JW; Farin FM; Stanczyk FZ; McTiernan A
    Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):94-101. PubMed ID: 14744739
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polymorphisms in genes involved in the estrogen pathway and mammographic density.
    Dumas I; Diorio C
    BMC Cancer; 2010 Nov; 10():636. PubMed ID: 21092186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polymorphism in xenobiotic and estrogen metabolizing genes, exposure to perfluorinated compounds and subsequent breast cancer risk: A nested case-control study in the Danish National Birth Cohort.
    Ghisari M; Long M; Røge DM; Olsen J; Bonefeld-Jørgensen EC
    Environ Res; 2017 Apr; 154():325-333. PubMed ID: 28157646
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polymorphisms in steroid hormone pathway genes and mammographic density.
    Haiman CA; Hankinson SE; De Vivo I; Guillemette C; Ishibe N; Hunter DJ; Byrne C
    Breast Cancer Res Treat; 2003 Jan; 77(1):27-36. PubMed ID: 12602902
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer.
    Yim DS; Parkb SK; Yoo KY; Yoon KS; Chung HH; Kang HL; Ahn SH; Noh DY; Choe KJ; Jang IJ; Shin SG; Strickland PT; Hirvonen A; Kang D
    Pharmacogenetics; 2001 Jun; 11(4):279-86. PubMed ID: 11434504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CYP1B1 and CYP19 gene polymorphisms and breast cancer incidence: no association in the ARIC study.
    Thyagarajan B; Brott M; Mink P; Folsom AR; Anderson KE; Oetting WS; Gross M
    Cancer Lett; 2004 Apr; 207(2):183-9. PubMed ID: 15072827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.